Therefore, we hypothesized that the BRD4 inhibitor I-BET-762 could reduce HO-1 expression and, consequently, reduce the tumor-promoting polarization of macrophages in KC mice stimulated with caerulein. The gene discussed is BRD4; the disease is keratoconus.